October 26, 2018
Abbott Laboratories and AbbVie Inc. will fork over $25 million to end a whistleblower's False Claims Act case alleging off-label promotion of triglyceride drug TriCor and unlawful kickbacks in the form of gift baskets and gift cards, the U.S. Department of Justice said Friday.
August 12, 2016
A Pennsylvania federal judge overseeing parts of a whistleblower case against Abbott Laboratories over alleged kickbacks and off-label marketing ordered the drugmaker on Thursday to produce some deposition testimony from an earlier antitrust case concerning cholesterol drug TriCor, finding there is some subject matter overlap.
June 22, 2015
The relator in a False Claims Act suit against Abbott Laboratories over alleged kickbacks and off-label marketing on Friday urged a Pennsylvania federal judge to compel the company to produce documents, denying its claims that "hundreds of thousands" of documents had already been provided.
January 31, 2014
A Pennsylvania federal judge refused Thursday to dismiss a former Abbott Laboratories employee's suit claiming the company submitted false claims to government health programs by pushing its cholesterol drug TriCor for off-label uses and paying kickbacks to physicians.